Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Retigabine (Primary)
- Indications Lennox-Gastaut syndrome; Partial epilepsies
- Focus Pharmacodynamics
- Acronyms CERETI
- 01 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 06 Jan 2014 Planned End Date changed from 1 Nov 2013 to 1 Jan 2014.